THE ENIGMA OF HLA-MEDIATED ADVERSE DRUG REACTIONS: EPOXIDE BUT NOT CARBAMAZEPINE INDUCES THE BINDING OF HAPTENATED PEPTIDES TO HLA-B*15:02

被引：0
作者：
Simper, Gwendolin S. [1 ]
Celik, Alexander A. [1 ]
Ho, Gia-Gia T. [1 ]
Huyton, Trevor [2 ]
Kuhn, Joachim [3 ]
Blasczyk, Rainer [1 ]
Bade-Doeding, Christina [1 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Max Planck Inst, Gottingen, Germany
[3] Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany
来源：
HLA | 2018年 / 91卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
O1
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
  • [11] HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
    Dinh Van Nguyen
    Hieu Chi Chu
    Doan Van Nguyen
    Minh Hong Phan
    Craig, Timothy
    Baumgart, Karl
    van Nunen, Sheryl
    ASIA PACIFIC ALLERGY, 2015, 5 (02) : 68 - 77
  • [12] Temporal trends and patterns in carbamazepine use, related severe cutaneous adverse reactions, and HLA-B*15:02 screening: A nationwide study
    Lin, Chih-Wan
    Huang, Wei-I
    Chao, Pi-Hui
    Chen, Wen-Wen
    Hsiao, Fei-Yuan
    EPILEPSIA, 2018, 59 (12) : 2325 - 2339
  • [13] Evaluation of tagged SNPs for HLA markers, HLA-B*15:02 and HLA-A*31:01, that are used to predict carbamazepine induced adverse effects.
    Pungliya, Manish
    Dastane, Aditi
    Vetal, Sachin
    Shrivastava, Kavita
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01) : 17 - 17
  • [14] Differential Effects of HLA-B*15:11 and HLA-A*31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions
    Fukunaga, Koya
    Tsukagoshi, Eri
    Kurata, Maiko
    Mizukawa, Yoshiko
    Niihara, Hiroyuki
    Morita, Eishin
    Watanabe, Yuko
    Yamaguchi, Yukie
    Watanabe, Hideaki
    Nakajima, Saeko
    Nomura, Takashi
    Kabashima, Kenji
    Tohyama, Mikiko
    Azukizawa, Hiroaki
    Asada, Hideo
    Hasegawa, Akito
    Hama, Natsumi
    Ozeki, Takeshi
    Mashimo, Yoichi
    Sekine, Akihiro
    Matsunaga, Kayoko
    Tanaka, Yoichi
    Nakamura, Ryosuke
    Abe, Riichiro
    Mushiroda, Taisei
    Saito, Yoshiro
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (04) : 908 - 911.e7
  • [15] Evaluation of HLA-B*1502 RealFast Assay for Rapid Detection of HLA-B*15:02 Allele Prior to Initiation of Carbamazepine Therapy
    Kho, M.
    Tan, B.
    Chen, E.
    Oon, L.
    Chan, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11) : S17 - S17
  • [16] Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
    Amstutz, Ursula
    Shear, Neil H.
    Rieder, Michael J.
    Hwang, Soomi
    Fung, Vincent
    Nakamura, Hidefumi
    Connolly, Mary B.
    Ito, Shinya
    Carleton, Bruce C.
    EPILEPSIA, 2014, 55 (04) : 496 - 506
  • [17] Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides
    Puig, Montserrat
    Ananthula, Suryatheja
    Venna, Ramesh
    Polumuri, Swamy Kumar
    Mattson, Elliot
    Walker, Lacey M.
    Cardone, Marco
    Takahashi, Mayumi
    Su, Shan
    Boyd, Lisa F.
    Natarajan, Kannan
    Abdoulaeva, Galina
    Wu, Wells W.
    Roderiquez, Gregory
    Hildebrand, William H.
    Beaucage, Serge L.
    Li, Zhihua
    Margulies, David H.
    Norcross, Michael A.
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [18] HAPLOTYPE OF HLA-B*13:01/HLA-B*15:02 AND DAPSONE-INDUCED DRUG HYPERSENSITIVITY SYNDROME IN THAI
    Sukasem, Chonlaphat
    Tempark, Therdpong
    Satapornpong, Patompong
    Rerknimitr, Pawinee
    Klaewsongkram, Jettanong
    Tassaneeyakul, Wichittra
    HLA, 2017, 89 (06) : 470 - 471
  • [19] Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions
    Chen, Zhibin
    Liew, Danny
    Kwan, Patrick
    NEUROLOGY, 2014, 83 (22) : 2077 - 2084
  • [20] Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care
    Sung, Cynthia
    Tan, Liesbet
    Limenta, Michael
    Ganesan, Ganga
    Toh, Dorothy
    Chan, Cheng Leng
    FRONTIERS IN PHARMACOLOGY, 2020, 11
12345